A comparison of vitamin D activity in paired non-malignant and malignant human breast tissues

被引:12
|
作者
Suetani, Rachel J. [1 ]
Ho, Kristen [1 ]
Jindal, Shalini [2 ]
Manavis, Jim [3 ]
Neilsen, Paul M. [1 ]
Pishas, Kathleen I. [1 ]
Rippy, Elisabeth [5 ]
Bochner, Melissa [5 ]
Kollias, James [5 ]
Gill, P. Grantley [5 ]
Morris, Howard A. [4 ]
Callen, David F. [1 ]
机构
[1] Univ Adelaide, Ctr Personalised Canc Med, Breast Canc Genet Grp, Adelaide, SA 5005, Australia
[2] Univ Adelaide, Discipline Med, Dame Roma Mitchell Canc Res Lab, Adelaide, SA 5005, Australia
[3] SA Pathol, Ctr Neurol Dis, Adelaide, SA, Australia
[4] SA Pathol, Endocrine Bone Res Lab, Adelaide, SA, Australia
[5] Royal Adelaide Hosp, Breast Endocrine & Surg Oncol Unit, Adelaide, SA, Australia
基金
英国医学研究理事会;
关键词
Breast cancer; 1,25-Dihydroxyvitamin D; 25-Hydroxyvitamin D; Ex vivo breast tissue; D-RECEPTOR; D PATHWAY; CANCER; EXPRESSION; D-3; GROWTH; CELLS; METABOLISM; CYP27B1; RISK;
D O I
10.1016/j.mce.2012.06.022
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Links between a low vitamin D status and an increased risk of breast cancer have been observed in epidemiological studies. These links have been investigated in human tissue homogenates and cultured cell lines. We have used non-malignant, malignant and normal reduction mammoplasty breast tissues to investigate the biological and metabolic consequences of the application of vitamin D to intact ex vivo human breast tissue. Tissues were exposed to 1 alpha,25(OH)(2)D-3 (1,250; active metabolite) and 25(OH)D (25D; pre-metabolite). Changes in mRNA expression and protein expression after vitamin D exposure were analysed. Results indicate that while responses in normal and non-malignant breast tissues are similar between individuals, different tumour tissues are highly variable with regards to their gene expression and biological response. Collectively, malignant breast tissue responds well to active 1,25D, but not to the inactive pre-metabolite 25D. This may have consequences for the recommendation of vitamin D supplementation in breast cancer patients. (C) 2012 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:202 / 210
页数:9
相关论文
共 50 条
  • [21] Immunohistochemical study of the BCAR1/p130Cas protein in non-malignant and malignant human breast tissue
    van der Flier, S
    van der Kwast, TH
    Claassen, CJC
    Timmermans, M
    Brinkman, A
    Henzen-Logmans, SC
    Foekens, JA
    Dorssers, LCJ
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2001, 16 (03) : 172 - 178
  • [22] Epidemiology of Malignant and Non-Malignant Primary Brain Tumors in Jordan
    Tamimi, Ahmad F.
    Tamimi, Iskandar
    Abdelaziz, Mohamad
    Saleh, Qusai
    Obeidat, Fatimah
    Al-Husseini, Maisa
    Haddadin, William
    Tamimi, Faleh
    NEUROEPIDEMIOLOGY, 2015, 45 (02) : 100 - 108
  • [23] The role of non-malignant B cells in malignant hematologic diseases
    Gao, Daquan
    HEMATOLOGY, 2025, 30 (01)
  • [24] Influence of Calcitriol on Prostaglandin- and Vitamin D-metabolising Enzymes in Benign and Malignant Breast Cell Lines
    Thill, Marc
    Cordes, Tim
    Hoellen, Friederike
    Becker, Steffi
    Dittmer, Christine
    Kuemmel, Sherko
    Salehin, Darius
    Friedrich, Michael
    Diedrich, Klaus
    Koester, Frank
    ANTICANCER RESEARCH, 2012, 32 (01) : 359 - 365
  • [25] Extracellular vesicle-mediated phenotype switching in malignant and non-malignant colon cells
    Mulvey, Hillary E.
    Chang, Audrey
    Adler, Jason
    Del Tatto, Michael
    Perez, Kimberly
    Quesenberry, Peter J.
    Chatterjee, Devasis
    BMC CANCER, 2015, 15
  • [26] Kinetic characterization of malate dehydrogenase in normal and malignant human breast tissues
    Abtahi, Najme Sadat
    Shahriari, Ali
    Talaiezadeh, Abdolhassan
    Fathizadeh, Payam
    BIOMEDICAL RESEARCH-INDIA, 2017, 28 (10): : 4329 - 4334
  • [27] DEGRO practical guidelines for radiotherapy of non-malignant disorders
    Reichl, Berthold
    Block, Andreas
    Schaefer, Ulrich
    Bert, Christoph
    Mueller, Reinhold
    Jung, Horst
    Roedel, Franz
    STRAHLENTHERAPIE UND ONKOLOGIE, 2015, 191 (09) : 701 - 709
  • [28] Lack of cyclin E immunoreactivity in non-malignant breast and association with proliferation in breast cancer
    Scott, KA
    Walker, RA
    BRITISH JOURNAL OF CANCER, 1997, 76 (10) : 1288 - 1292
  • [29] Complete prevalence of primary malignant and non-malignant brain tumors in comparison to other cancers in the United States
    Neff, Corey
    Price, Mackenzie
    Cioffi, Gino
    Kruchko, Carol
    Waite, Kristin A.
    Barnholtz-Sloan, Jill S.
    Ostrom, Quinn T.
    CANCER, 2023, 129 (16) : 2514 - 2521
  • [30] Eltrombopag for the treatment of thrombocytopenia in patients with malignant and non-malignant hematologic disorders
    Pathak, Swati
    Roth, Michael
    Verma, Amit
    Steidl, Ulrich
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2013, 9 (12) : 1667 - 1675